Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Do you use CNS dosing of antibiotics for any portion of the treatment course in patients with infective endocarditis who have cerebral emboli?
Related Questions
What is your typical approach to antibiotic management for severe necrotizing MSSA pneumonia with concurrent MSSA bacteremia assuming no overt antibiotic contraindications and TTE without evidence of endocarditis?
Would you recommend avoiding intravesical (bladder) tobramycin administration in a patient with advanced chronic kidney disease?
How long do you treat Staphylococcus aureus pyomyositis with antibiotics?
Under what circumstances would you treat a patient with an aortic graft infection for greater than 6 weeks of antibiotic therapy, whom has undergone total graft explanation and replacement?
How would you manage MRSA and Enterococcus faecalis bacteriuria in a patient presenting in severe heart failure without urinary symptoms, fever, or chills, two negative blood cultures, and whose transthoracic echocardiogram shows no new valvular abnormalities?
How do you approach the use of Paxlovid in patients with COVID-19 and CKD Stage 4?
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
Do you recommend the use of ampicillin/ceftriaxone for prosthetic valve endocarditis due to ampicillin-susceptible Enterococcus faecium?
What are your vaccine recommendations while patients are on biologics?
What criteria should be used to determine the timing of placing central venous access or cardiac devices in patients with Staphylococcus lugdunensis infective endocarditis, considering the skip phenomenon?
